The effect of omalizumab treatment on inflammatory parameters in urticarial diseases: a retrospective study.

Postepy Dermatol Alergol · 2026 · PMC13217151 · PMID 42222458

Europe PMC DOI

hedged sentence

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

did not reach statistical significancep = 0.097so close (0.05 < p ≤ 0.1)

Although CRP levels also decreased, the change did not reach statistical significance ( p = 0.097).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.